Joseph Lucchese - 27 Sep 2021 Form 4 Insider Report for Timber Pharmaceuticals, Inc.

Role
CFO, Executive VP & Treasurer
Signature
/s/ Joseph Lucchese
Issuer symbol
N/A
Transactions as of
27 Sep 2021
Net transactions value
$0
Form type
4
Filing time
29 Sep 2021, 08:04:45 UTC
Next filing
19 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMBR Stock Option (right to buy) Award $0 +361,163 $0.000000 361,163 27 Sep 2021 Common Stock, par value $0.001 per share 361,163 $0.9180 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the options vest on September 27, 2022, and the remaining shares will become exercisable in equal 36 monthly installments beginning on October 27, 2022, as long as the reporting person remains continuously employed through each vesting date.